Syngene International Ltd Analyst Rating
based on 8 analysts
50.00%
Buy
0.00%
Hold
50.00%
Sell
Based on 8 analysts offering long term price targets for Syngene International Ltd. An average target of ₹862.5
Source: S&P Global Market Intelligence
Syngene International Ltd Share analysis
Syngene International Ltd price forecast by 8 analysts
Upside of1.48%
High
₹1030
Target
₹862.50
Low
₹700
Syngene International Ltd target price ₹862.5, a slight upside of 1.48% compared to current price of ₹844. According to 8 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Syngene International Ltd revenue growth forecast
Expected growth rate Q1, FY2026:27.30%
Forecast
Actual
Including amortisation and stock based compensations
Syngene International Ltd EPS growth forecast
EPS estimate Q1, FY2026:32.62%
Forecast
Actual
Source: S&P Global Market Intelligence
Syngene International Ltd Performance
Day's Low
Day's High
₹840Day's Price Range₹855.452 Week's Low
52 Week's High
₹607.6552-Week Price Range₹960.6
| Returns % | |
| 1 Month Return | + 0.36 % |
| 3 Month Return | -4.93 % |
| 1 Year Return | + 24.52 % |
| Market Stats | |
| Previous Close | ₹849.95 |
| Open | ₹849.95 |
| Volume | 6.46L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹34,596.04Cr |
Syngene International Ltd Key Statistics
| P/E Ratio | 70.77 |
| PEG Ratio | -221.16 |
| Market Cap | ₹34,596.04 Cr |
| P/B Ratio | 6.73 |
| EPS | 12.69 |
| Dividend Yield | 0.18 |
| Sector | Healthcare |
| ROE | 11.95 |
Syngene International Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹34,596.04 Cr | 34.82% | 0.56 | ₹510 Cr | ₹3,488 Cr | |
| BUY | ₹14,100.35 Cr | -2.24% | 0.52 | ₹602 Cr | ₹2,851 Cr | |
| BUY | ₹73,098.77 Cr | 33.6% | 0.56 | ₹3,168 Cr | ₹29,001 Cr | |
| HOLD | ₹98,565.65 Cr | 55.28% | 0.64 | ₹3,854 Cr | ₹19,547 Cr | |
| BUY | ₹59,732.90 Cr | 24.06% | 0.53 | NA | NA |
Syngene International Ltd Mutual Fund Holdings
About Syngene International Ltd
Share Price: ₹844.00 per share as on 20 Dec, 2024 04:01 PM
Market Capitalisation: ₹34,596.04Cr as of today
Revenue: ₹891.00Cr as on September 2024 (Q3 24)
Net Profit: ₹106.10Cr as on September 2024 (Q3 24)
Listing date: 11 Aug, 2015
Chairperson Name: Kiran Mazumdar Shaw
| Organisation | Syngene International Ltd |
| Headquarters | |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Syngene International Ltd
Biocon Reduces Stake in Syngene Through Sale - 13 Dec, 2024
Biocon announced the sale of 80 lakh equity shares of Syngene International, raising ₹686 crore and reducing its shareholding to 52.46%. Despite a slight decline, Syngene has increased investor wealth by 23% over the past year.Syngene Shares Surge After Biocon Stake Sale - 11 Dec, 2024
Following Biocon's sale of a 1.19% stake in Syngene International for Rs 686.14 crore, shares surged nearly 4%, reflecting strong trading volumes and investor interest.Biocon Divests Stake; Syngene Reports Decline - 10 Dec, 2024
Biocon Ltd sold a 2% stake in Syngene International for ₹686 crore, leading to a decline in promoter shareholding. Syngene's Q2FY25 revenue and profit also fell.Syngene Reports Decline in Revenue and Profit - 09 Dec, 2024
Syngene International's Q2 FY2025 revenue fell to ₹891 crore, with net profit down 8.9% to ₹106.1 crore. The stock faced pressure amid market uncertainties.Syngene International Shares Decline, Market Cap Drops - 18 Nov, 2024
Syngene International's shares fell by 2.19% today, closing at Rs 842.75, resulting in a market cap loss of Rs 760 crore, totaling Rs 33,923.80 crore.
Insights on Syngene International Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 839.8 Cr → 907.5 Cr (in ₹), with an average increase of 7.5% per quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, SYNGENE stock has moved up by 1.0%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 75.7 Cr → 106.1 Cr (in ₹), with an average increase of 28.7% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 20.63% to 20.72% in Sep 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Vimta Labs Ltd has given 159.7% return, outperforming this stock by 111.4%
- NO EFFECT
Against Peers
In the last 1 year, Vimta Labs Ltd has given 147.3% return, outperforming this stock by 125.0%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 54.72% of holdings in Sep 2024 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 7.42% to 6.74% in Sep 2024 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 13.63% to 13.58% in Sep 2024 quarter
Syngene International Ltd Financials
Index Inclusions
Syngene International Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 54.72% | 0.00 | |
| Foreign Institutions | 20.72% | 0.42 | |
| Mutual Funds | 13.58% | ||
| Retail Investors | 6.74% | ||
| Others | 4.24% | 18.11 |
Syngene International Ltd Key Indicators
Syngene International Ltd Valuation
Syngene International Ltd in the last 5 years
Lowest (23.09x)
March 31, 2020
Today (70.77x)
December 19, 2024
Industry (105.00x)
December 19, 2024
Highest (78.92x)
December 2, 2024
Syngene International Ltd Earnings and Dividends
Syngene International Ltd Earnings Results
Syngene International Ltd’s net profit fell -8.93% since last year same period to ₹106.10Cr in the Q2 2024-2025. On a quarterly growth basis, Syngene International Ltd has generated 40.16% jump in its net profits since last 3-months.
Read More about Earnings ResultsSyngene International Ltd Dividends April,2024
In the quarter ending March 2024, Syngene International Ltd has declared dividend of ₹1.25 - translating a dividend yield of 0.30%.
Read More about Dividends
Syngene International Ltd Technicals Summary
Bearish
Neutral
Bullish
Syngene International Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Syngene International Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Syngene International Ltd shares.
Syngene International Ltd (SYNGENE) share price today is ₹844
Syngene International Ltd is listed on NSE
Syngene International Ltd is listed on BSE
- Today’s highest price of Syngene International Ltd is ₹855.4.
- Today’s lowest price of Syngene International Ltd is ₹840.
PE Ratio of Syngene International Ltd is 70.77
PE ratio = Syngene International Ltd Market price per share / Syngene International Ltd Earnings per share
Today’s traded volume of Syngene International Ltd(SYNGENE) is 6.46L.
Today’s market capitalisation of Syngene International Ltd(SYNGENE) is ₹34596.04Cr.
| Syngene International Ltd(SYNGENE | Price |
|---|---|
52 Week High | ₹960.6 |
52 Week Low | ₹607.65 |
Syngene International Ltd(SYNGENE) share price is ₹844. It is down -12.14% from its 52 Week High price of ₹960.6
Syngene International Ltd(SYNGENE) share price is ₹844. It is up 38.90% from its 52 Week Low price of ₹607.65
| Syngene International Ltd(SYNGENE | Returns |
|---|---|
1 Day Returns | -5.95% |
1 Month Returns | 0.36% |
3 Month Returns | -4.93% |
1 Year Returns | 24.52% |